Fisetin Inhibits Osteoclastogenesis Through Prevention of RANKL-Induced ROS Production by Nrf2-Mediated Up-regulation of Phase II Antioxidant Enzymes

Eiko Sakai(Nagasaki University), Takayuki Tsukuba(University of Nagasaki)
Journal of Pharmacological Sciences
January 1, 2013
Cited by 63


Related Papers